{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:01Z","timestamp":1787026561078,"version":"build-2736575974"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer is a significant malignancy, for which prognostic prediction and understanding of the tumor immune microenvironment are crucial. B cells play a key regulatory role in this environment, making their study essential for advancing bladder cancer research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, a multi-omics analysis strategy combining single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq was used to establish single-cell transcriptome profiles of tumor tissues from bladder cancer patients, focusing on B-cell populations and their interactions with other cell types in the tumor microenvironment. Large public databases were used to screen for key prognostic genes associated with bladder cancer B cells, and their biomarker expression was verified by\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on tumor samples from eight patients with bladder cancer and four normal samples, we selected 84, 967 cells for single-cell sequencing analysis. From these, we identified 10, 967 B cells and identified 508 key genes associated with B cells in bladder cancer from five different B cell subtypes. By integrating a large amount of RNA sequencing data, we identified\n                      <jats:italic>VCL<\/jats:italic>\n                      ,\n                      <jats:italic>FLNA<\/jats:italic>\n                      ,\n                      <jats:italic>TAGLN<\/jats:italic>\n                      ,\n                      <jats:italic>ACTA2<\/jats:italic>\n                      ,\n                      <jats:italic>COL6A2<\/jats:italic>\n                      , and\n                      <jats:italic>CALD1<\/jats:italic>\n                      as potential biomarkers for B-cell-associated bladder cancer, and experimentally verified that these markers were significantly lower in bladder cancer patients than in the normal group, and were effective in predicting the survival rate of the patients and the status of the tumor immune microenvironment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using a combination of transcriptomic and experimental validation at single-cell and batch levels, this study provides insights into the key gene signatures of B cells from patients with bladder cancer and their roles in regulating the tumor immune microenvironment, providing new biomarkers and potential therapeutic targets for predicting patient\u2019 prognosis and immunotherapy response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1600254","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:30:31Z","timestamp":1760679031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive analysis of single-cell and bulk transcriptomes reveals key B-cell genes and immune microenvironment regulation in bladder cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA: Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.09.025","article-title":"Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer","volume":"37","author":"Genitsch","year":"2019","journal-title":"Urol Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/jpm13050756","article-title":"Precision medicine in bladder cancer: present challenges and future directions","volume":"13","author":"Mohanty","year":"2023","journal-title":"J Personalized Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":":5670","DOI":"10.3390\/ijms21165670","article-title":"Evolution of urothelial bladder cancer in the context of molecular classifications","volume":"21","author":"Minoli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.167","article-title":"Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer","volume":"6","author":"Ottley","year":"2020","journal-title":"J Pathol Clin Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2021.07.005","article-title":"Biomarkers in muscle invasive bladder cancer","volume":"107","author":"Wilson","year":"2022","journal-title":"Adv Clin Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet (London England)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/jama.2020.17601","article-title":"Bladder cancer","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: Cancer J Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21471","article-title":"Genomic analysis of tumor microenvironment immune types across 14 solid cancer types: immunotherapeutic implications","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","article-title":"Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy","volume":"11","author":"Zhang","year":"2023","journal-title":"biomark Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0214-4","article-title":"Revolutionizing immunology with single-cell RNA sequencing","volume":"16","author":"Chen","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e121387","DOI":"10.1172\/jci.insight.121387","article-title":"Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes","volume":"4","author":"Ma","year":"2019","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3971","article-title":"Diffusion pseudotime robustly reconstructs lineage branching","volume":"13","author":"Haghverdi","year":"2016","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1010830","DOI":"10.1371\/journal.pcbi.1010830","article-title":"SurvivalPath:A R package for conducting personalized survival path mapping based on time-series survival data","volume":"19","author":"Shen","year":"2023","journal-title":"PloS Comput Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cmet.2016.08.020","article-title":"Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes","volume":"24","author":"Segerstolpe","year":"2016","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01003-3","article-title":"Emerging clinical applications of single-cell RNA sequencing in oncology","volume":"22","author":"Boxer","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.70099","article-title":"Single-cell insights into the role of T cells in B-cell Malignancies","author":"Lla\u00f3-Cid","year":"2025","journal-title":"FEBS Lett"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31850","article-title":"A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity","volume":"144","author":"Liu","year":"2019","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803773","article-title":"In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy","volume":"183","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203279","article-title":"Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with Malignancies","volume":"190","author":"Zirakzadeh","year":"2013","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.9952","article-title":"Differentially expressed genes ASPN, COL1A1, FN1, VCAN and MUC5AC are potential prognostic biomarkers for gastric cancer","volume":"17","author":"Jiang","year":"2019","journal-title":"Oncol Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10403","article-title":"MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-022-03510-1","article-title":"Fibronectin 1 as a key gene in the genesis and progression of cadmium-related bladder cancer","volume":"201","author":"Zhang","year":"2023","journal-title":"Biol Trace Element Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.672098","article-title":"Alterations of growth and focal adhesion molecules in human breast cancer cells exposed to the random positioning machine","volume":"9","author":"Sahana","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12894-021-00857-w","article-title":"Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysis","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Urol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.05.054","article-title":"Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer","volume":"626","author":"Wu","year":"2017","journal-title":"Gene"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.12.044","article-title":"An adventitious interaction of filamin A with RhoGDI2(Tyr153Glu)","volume":"469","author":"Song","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1772-y","article-title":"Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis","volume":"50","author":"Wang","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-20-0513","article-title":"TAGLN is downregulated by TRAF6-mediated proteasomal degradation in prostate cancer cells","volume":"19","author":"Wen","year":"2021","journal-title":"Mol Cancer Res: MCR"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e13847","DOI":"10.1097\/MD.0000000000013847","article-title":"CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.04.007","article-title":"Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease","volume":"84","author":"Guo","year":"2009","journal-title":"Am J Hum Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41065-020-00165-7","article-title":"Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes","volume":"158","author":"Chen","year":"2021","journal-title":"Hereditas"},{"key":"B48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00438-024-02156-z","article-title":"A novel cancer-associated fibroblasts risk score model predict survival and immunotherapy in lung adenocarcinoma","volume":"299","author":"Kong","year":"2024","journal-title":"Mol Genet Genom: MGG"},{"key":"B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijo.2021.5217","article-title":"Collagen type VI\u2212\u03b11 and 2 repress the proliferation, migration and invasion of bladder cancer cells","volume":"59","author":"Piao","year":"2021","journal-title":"Int J Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e11-02-0165","article-title":"Caldesmon regulates actin dynamics to influence cranial neural crest migration in Xenopus","volume":"22","author":"Nie","year":"2011","journal-title":"Mol Biol Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12935-021-01896-x","article-title":"The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer","volume":"21","author":"Du","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000397","article-title":"Status quo of p53 in the treatment of tumors","volume":"27","author":"Guan","year":"2016","journal-title":"Anti-cancer Drugs"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1496640","article-title":"Discovering biomarkers associated with infiltration of CD8(+) T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.88","article-title":"Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH","volume":"29","author":"Lotan","year":"2016","journal-title":"Modern Pathol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19217","article-title":"PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort","volume":"8","author":"Lotan","year":"2017","journal-title":"Oncotarget"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1038\/s41598-017-03321-8","article-title":"The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:30:32Z","timestamp":1760679032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2025.1600254"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1600254","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"1600254"}}